Commercialization advisory · Healthcare & life sciences

Strategy. Partnerships. Execution.

EC Strategic Advisors help turn innovation into commercial growth, from validating the opportunity to signing the agreement.

Speak with us See what we do →

0 days

Target window for meaningful market progress

Since 0

Over three decades of experience

0 territories & countries

Commercialization of biotech, healthcare and life science products

Two generations

One focus: helping our clients grow

Where we have commercialized medical and healthcare products

USA · Canada · Mexico · Brazil · Argentina · Chile · United Kingdom · Switzerland · South Africa · Japan · South Korea · Taiwan · China · Philippines · Singapore · Malaysia · Indonesia · Thailand · India · Mongolia · Myanmar · Hong Kong · Australia · Russia

Biotechnology Pharmaceuticals Medical diagnostics Medical devices Digital health Healthcare services

Who we work with

Innovation is rarely the constraint. Commercialization is.

We work primarily with companies in biotechnology, pharmaceuticals, medical diagnostics, medical devices, digital health, and healthcare services. Through strategic advisory, business development, and execution support, we help clients move.

We help clients

Validate market opportunities

Enter new markets

Build commercial partnerships

Strengthen sales channels

Generate revenue

Where we come in

The situations we commonly support

All of what we do →

Situation one

Validating a Minimum Viable Product

The goal: turn a promising product into a validated commercial opportunity.

Situation two

Scaling Product-Market Fit

The goal: turn early traction into sustainable and repeatable growth.

Situation three

Expanding a Mature Product

The goal: unlock new revenue streams and maximize long-term product value.

Our services

What we actually deliver

→ Strategic Advisory Where and how the business should grow, documented as a plan you can act on. → Business & Partnership Development The right partners identified, engaged and negotiated to a defined outcome. → Execution Support We run the outreach, pipeline and negotiations alongside your team.

Our approach

Understand, Assess, Strategize, Activate, Execute

STEP 1

Understand

One to two days

STEP 2

Assess

Three to five days

STEP 3

Strategize

One to two weeks

STEP 4

Activate

Four to eight weeks

STEP 5

Execute

Through to handover

We typically work on a project-fee basis, combined with a success-based incentive. Wherever possible, we aim to achieve meaningful market progress within 100 days.

100

days

Fees aligned to outcomes, not to hours. Most engagements aim to show commercial movement inside one quarter.

The network behind the work

Advisory is only as valuable as the doors it can open.

ECSA's reach is built on business and consulting relationships developed since 1989, complemented by a venture fund and venture studio operating across Asia, Europe and North America. These are trusted relationships built over decades, not contacts assembled for a project.

Sunstone Group

Established in 1989

Eagle Venture Studio Asia

Go-to-market acceleration

Eagle Venture Fund

B2B technology investment

Dr. Carl Thong

General Partner at Eagle Venture Fund. Adjunct Professor at Singapore Management University. YPO member. Founder of Sunstone Group.

Meet the partners →

Ethan Thong and Dr. Carl Thong working together

Two generations.One focus.

Ethan brings energy, curiosity, adaptability, and a next-generation perspective. Carl brings decades of entrepreneurial experience and trusted global relationships. Together, we combine fresh thinking with experienced execution.

About the firm →

Let's Talk

Speak with us about your technology, market opportunity, and growth objectives.

Start a conversation